A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update

CN Sternberg; RE Hawkins; J Wagstaff; P Salman; J Mardiak; CH Barrios; JJ Zarba; OA Gladkov; E Lee; C Szczylik; L McCann; SD Rubin; M Chen; ID Davis

A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update

CN Sternberg, RE Hawkins, J Wagstaff, P Salman, J Mardiak, CH Barrios, JJ Zarba, OA Gladkov, E Lee, C Szczylik, L McCann, SD Rubin, M Chen, ID Davis

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1287-1296
Number of pages	9
Journal	European Journal of Cancer
Volume	49
Issue number	6
Publication status	Published - 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Sternberg, CN., Hawkins, RE., Wagstaff, J., Salman, P., Mardiak, J., Barrios, CH., Zarba, JJ., Gladkov, OA., Lee, E., Szczylik, C., McCann, L., Rubin, SD., Chen, M., & Davis, ID. (2013). A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update. European Journal of Cancer, 49(6), 1287-1296.

@article{7323f36ef71f4f61a85be9efb2276976,

title = "A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update",

author = "CN Sternberg and RE Hawkins and J Wagstaff and P Salman and J Mardiak and CH Barrios and JJ Zarba and OA Gladkov and E Lee and C Szczylik and L McCann and SD Rubin and M Chen and ID Davis",

year = "2013",

language = "English",

volume = "49",

pages = "1287--1296",

journal = "European Journal of Cancer",

issn = "1879-0852",

publisher = "Elsevier BV",

number = "6",

}

Sternberg, CN, Hawkins, RE, Wagstaff, J, Salman, P, Mardiak, J, Barrios, CH, Zarba, JJ, Gladkov, OA, Lee, E, Szczylik, C, McCann, L, Rubin, SD, Chen, M & Davis, ID 2013, 'A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update', European Journal of Cancer, vol. 49, no. 6, pp. 1287-1296.

TY - JOUR

T1 - A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update

AU - Sternberg, CN

AU - Hawkins, RE

AU - Wagstaff, J

AU - Salman, P

AU - Mardiak, J

AU - Barrios, CH

AU - Zarba, JJ

AU - Gladkov, OA

AU - Lee, E

AU - Szczylik, C

AU - McCann, L

AU - Rubin, SD

AU - Chen, M

AU - Davis, ID

PY - 2013

Y1 - 2013

M3 - Article

SN - 1879-0852

VL - 49

SP - 1287

EP - 1296

JO - European Journal of Cancer

JF - European Journal of Cancer

IS - 6

ER -